PGWC seeks to improve global equity and access in healthcare by providing economically accessible and practical solutions to universal needs, designed to be relevant across all geographies, cultures, economies and healthcare delivery systems.
At PGWC we:
- design materials and manufacturing methods to reduce the costs of advanced technologies without compromising efficacy.
- implement business structures designed to incentivize partners throughout the value chain.
- focus on the needs of populations in underserved markets, resulting in improved patient outcomes and cost savings to healthcare systems worldwide.
- build on our deep understanding of nanomaterials and their applications in healthcare, with an initial focus on one of the world’s greatest “silent epidemics” – chronic wounds.
Our Founders and Management Team
The founding partners of PGWC include 2 world-class scientists in nanomaterials engineering and nanomedicine, with research affiliations and professorships at leading institutions including Stanford University, Harvard Brigham Women’s Hospital and Michigan State University in the US and the Max Planck Institute and University of Siegen in Germany. Both began their careers at the renowned nanomaterials research institute of the University of Tehran. The science team is supported by a leader in international business development in engineering and manufacturing and a professional with 25+ years of experience in the introduction of novel medical device technologies in international markets. Management is further supported by a network of experts in wound care technologies and markets.
Prof. Morteza Mahmoudi, PhD – Founding Partner and Chair of Scientific Advisory Board
Assistant Professor, Precision Health Program, Michigan State University and member of the Connors Center for Women’s Health & Gender Biology at Brigham Women’s Hospital, Harvard Medical School. Previous postings include: Assistant Professor at Harvard Medical School; Visiting Professor Stanford University School of Medicine. Founder of the “NanoBiotechnology” group. Author of >250 papers (>27,000 citations) with >12 issued/pending US and International patents. He is among 2018 and 2020 highly cited researchers, as reported by Clarivate Analytics. His specific research interest is in nanomedicine and regenerative medicine for the development of new nano-based platforms for prevention/treatment of life-threatening conditions such as cardiomyopathy, cancer, neurodegenerative diseases and chronic wounds.
Role and responsibilities at PGWC: Morteza guides the development of the technology and the related scientific documentation. He is also active in international Wound Care Societies and has a network of clinician colleagues active in wound care.
Prof. Mohammad Raoufi, PhD – Founding Partner and Lead Materials Scientist
Co-inventor of proprietary nanofibre extrusion process. Visiting Professor at University of Siegen, Germany. Assistant Professor at Tehran University and Researcher at Max Planck Institute. 9 years of experience as R&D scientist and project leader, teaching in nanotechnology, polymer physics, physical chemistry and biophysics. Skilled in Tissue engineering and Protein Interactions. Experience in innovation and business development and digitalization. >20 scientific papers in international journals, multiple patents pending.
Role and responsibilities at PGWC: Mohammad drives process development involving materials selection, characterization, biological evaluation and feasibility testing.
Mart Pearson - Founding Partner and Managing Director
More than 25 years’ experience in medical device start-ups, with roles including Managing Director, VP Europe, VP International. Strategic planning and international business development, with extensive experience in introduction of new technologies to new markets, working with early-stage medical device companies.
Role and responsibilities at PGWC: Mart is responsible for the overall business structure and communications, coordination of resources, identification of strategic objectives and pathways and the implementation of company plans.
Jafar Javadi - Founding Partner, Chairman and Financial Advisor
Jafar has over 30 years’ experience within the industrial sector, including automotive and renewable energies in which he has 20 years’ experience as founder and managing director.
Role and responsibilities at PGWC: Jafar coordinates the process engineering aspects of scaling the technology and advises on all budget related matters, providing consultation on project management to ensure that overall project costs are effectively managed. He is also responsible for corporate governance and participates in fundraising and finance efforts.
Samad Javadi - Partner, Head of Finance
Samad has over 10 years’ experience in financial services working in the fixed income sales & trading divisions of top tier investment banks (Morgan Stanley, Goldman Sachs, and Barclays) specializing in structured investment and hedging solutions for financial institutions. Samad holds a Master’s degree in International Management from Bocconi University in Milan and a BSc in Business Administration from the University of Turin.
Role and responsibilities at PGWC: Samad’s main role is in fundraising and investor relations as well as advising on budgeting and business planning.
Andrew Adams - Wound Market Consulting
Andrew brings global wound care market awareness based on his decades of experience in the field. He advises on strategy and implementation and coordinates aspects of PGWC’s development plans.
Chad Coberly, JD, MBA
Chad has managed IP, Legal, Quality Assurance, Clinical and Regulatory Affairs efforts in multiple medical device start-up companies and will help guide PGWC efforts in all of these areas. Background: 20+ years in corporate legal, regulatory, clinical, IP, licensing, M&A, and business development in medical devices.
Keith Heaton - i2r Medical
Keith supports PGWC in the development of our intellectual property portfolio strategy and in the implementation and management of our Quality Systems. Experience: KCI, Acelity
Chris Lay MBA, PhD
Chris is deeply embedded in the venture investment world, providing insights on investor expectations and valuation approaches. Background: CEO, CFO, COO in healthcare technology, financial services, venture capital. Neurobiologist and entrepreneur.
PGWC-led Consortium Awarded Eureka Eurostars-2 Grant. The consortium’s application was ranked 11th out of 560 submissions by Eureka, the largest international funding organization for Small and Mid-Size Enterprise. Partners in Global Wound Card (PGWC) announced today that the company’s grant application to support the development of its nano-X skin substitute for chronic wounds received a ranking of 11 out of 560 eligible applications in the Eurostars-2 competition, a joint program sponsored...